Regeneron Pharmaceuticals, Inc. ( REGN) - Key Metrics

REGN Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $41.50 $12.54 $5.56 $3.23
2026Q1 $34.67 $6.99 $10.37 $8.16
2025Q4 $37.75 $8.21 $11.38 $8.96
2025Q3 $36.23 $14.09 $15.62 $13.68
2025Q2 $34.97 $13.24 $10.89 $9.21

REGN Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 7.46% 12.38
2026Q1 13.45% 27.63
2025Q4 10.98% 23.50
2025Q3 6.25% 9.98
2025Q2 6.65% 9.91

REGN Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.52% 0.15%
2026Q1 1.06% 0.12%
2025Q4 1.16% 0.12%
2025Q3 2.43% 0.16%
2025Q2 1.75% 0.17%

REGN

Price: $799.08

52 week price:
538.87
840.84

Dividend Yield: 0.48%

5-year range yield:
0.48%
0.63%

Forward Dividend Yield: 0.47%

Payout Ratio Range:
1.95%
425.53%

Dividend Per Share: 3.76 USD

Earnings Per Share: 40.47 USD

P/E Ratio: 18.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 417600

Ebitda: 597.4 million

Market Capitalization: 78.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 2

Links: